Kiromic Biopharma, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kiromic Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Kiromic Biopharma, Inc. Depreciation for the quarter ending September 30, 2024 was $552K, a 1.43% decline year-over-year.
  • Kiromic Biopharma, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.22M, a 0.01% increase year-over-year.
  • Kiromic Biopharma, Inc. annual Depreciation for 2023 was $2.22M, a 32.7% increase from 2022.
  • Kiromic Biopharma, Inc. annual Depreciation for 2022 was $1.67M, a 256% increase from 2021.
  • Kiromic Biopharma, Inc. annual Depreciation for 2021 was $470K, a 135% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.22M +$548K +32.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.67M +$1.2M +256% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $470K +$270K +135% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $200K +$113K +129% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 $87.5K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.